Single dose of DMT offers lasting depression relief in clinical trial

neurosciencenews.com

A single dose of DMT provided rapid and lasting relief from depression in a clinical trial. The Phase IIa study found that a brief intravenous dose of DMT, the psychoactive compound in ayahuasca, significantly reduced depression symptoms for up to six months. This short-acting psychedelic therapy could offer a more accessible and cost-effective treatment option for depression compared to longer-acting psychedelics.


With a significance score of 5.8, this news ranks in the top 0.4% of today's 30980 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: